Aptagen, LLC
A15 (ID# 8102)
RNA
Brain Endothelia Cell
Cells
48.74 ± 3.11 nM (reported value)
10 mmol/l HEPES, pH 7.4, 50 mmol/l NaCl, 1 mmol/l MgCl2, 1 mmol/l CaCl2, 0.01% bovine serum albumin
37°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
5’-rGprGprGprAprGprGprAprCprGprAprUprGprCprGprGprCprGprUprAprUprUprGprCprGprCprGprAprGprGprAprUprUprAprUprCprCprGprCprUprCprAprUprCprGprUprUprGprUprUprGprUprUprGprUprGprCprAprGprAprCprGprAprCprUprCprGprCprCprCprGprAp-3’
71
21775.7
650400
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Cheng C, Chen YH, Lennox KA, Behlke MA, Davidson BL. In vivo SELEX for Identification of Brain-penetrating Aptamers. Mol Ther Nucleic Acids. 2013;2(1):e67. Published 2013 Jan 8. doi:10.1038/mtna.2012.59
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.